PATENT CLAIM ANALYSIS

Application Number: 16263200
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
This disclosure relates to novel huntingtin targets. Novel oligonucleotides for the treatment of Huntington's disease are also provided.

Claim (Index 95):
The method of  claim 93 , wherein the rAAV is administered to one or more regions of the parenchyma of the brain, with at least one region being a putamen.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 99.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15089319', '15697120', '15814350', '15089437', '15419593']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8437931933128409
- 35 USC 102 Novelty (BERT): 0.6365418783897039
- Combined Prediction Score: 0.8230680618205272
- Mean Citation Score: 629.611414
- Max Citation Score: 801.5308
- Similarity Product: 523.0968601940872

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test